Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2009
10/07/2009CN101549155A Porcine circovirus type II inactivated vaccine of and method for preparing same
10/07/2009CN101549154A Compositions comprising neisseria meningitidis antigens from serogroups B and C as well as a further antigen
10/07/2009CN101549153A Composite and method for self-treating tumor
10/07/2009CN101549148A Application of polypeptide in preparing the medicine promoting the transformation from endocardium cell to interstitial cell
10/07/2009CN100547075C Her-2/neu DNA vaccine having anti-cancer activity
10/07/2009CN100547070C Attenuated circovirus
10/07/2009CN100547069C Production of viruses, viral isolates and vaccines
10/07/2009CN100547003C Antibodies to human IL-1 beta
10/07/2009CN100547002C Gene artificial synthesis and SARS virus protective antigen-amino acid series
10/07/2009CN100547001C HBV precore protein capable of forming particles
10/07/2009CN100546652C Deimmunized monoclonal antibodies for protection against and treating HIV infection
10/07/2009CN100546651C Method of producing intravenous injection human hepatitis b immune globulin
10/07/2009CN100546650C Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
10/07/2009CN100546649C Ultrasonic microvesicle as immuno adjuvant and vaccine carrier
10/06/2009USRE40930 Porcine adenovirus type 3 genome
10/06/2009US7598362 Hepatitis C virus vaccine
10/06/2009US7598354 Campylobacter glycans and glycopeptides
10/06/2009US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
10/06/2009US7598229 Metastatic colorectal cancer vaccine
10/06/2009US7598226 Compositions and methods for the therapy and diagnosis of breast cancer
10/06/2009US7598225 Generation of immune response to prostate-specific antigen (PSA)
10/06/2009US7598223 Methods for producing target cell reactive lymphocytes
10/06/2009US7598072 cell-free method for release of viral cores of enveloped viruses from endosomes
10/06/2009US7598046 Use of Apolipoprotein B, Apolipoprotein E, fragments for diagnostic, detection, prognostic and therapeutic applications In bovine spongiform encephalopathy (BSE) and Creutzfeld-Jacob Disease
10/06/2009US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer
10/06/2009US7598027 Botulinum toxin screening assays
10/06/2009US7597908 Use of microparticles with adsorbed antigen to stimulate immune responses
10/06/2009US7597896 Composition comprising a protein encoded by a modified ERP gene of Mycobacterium
10/06/2009US7597895 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis
10/06/2009US7597894 Antigen presenting cells and dendritic cells; inducing immunology response
10/06/2009US7597893 Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa
10/06/2009US7597892 Using cytokine specific immunolglobulin as therapeutic in treatment and prevention of skin disorders
10/06/2009US7597891 Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
10/06/2009US7597890 Methods and compositions for diagnosing lung cancer
10/06/2009US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009US7597888 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes
10/06/2009US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/06/2009US7597886 Tumor necrosis factor-gamma
10/06/2009CA2381348C Lck-derived peptides activating ctls
10/06/2009CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
10/06/2009CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/06/2009CA2310888C Monoclonal human natural antibodies
10/06/2009CA2284689C Animal model for evaluation of vaccines
10/06/2009CA2207779C Carcinoma treatment
10/06/2009CA2159106C Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
10/06/2009CA2111205C Polypeptides having kinase activity, their preparation and use
10/04/2009CA2625304A1 Androgen receptor related methods for treating bladder cancer
10/01/2009WO2009121065A2 Modulation and repletion/enhancement of the complement system for treatment of trauma
10/01/2009WO2009120966A2 Reinforced tissue graft
10/01/2009WO2009120954A2 Nicotine immunoconjugates
10/01/2009WO2009120927A2 Methods of treatment
10/01/2009WO2009120922A2 Compositions and methods for inhibiting pdgfrbeta and vegf-a
10/01/2009WO2009120905A2 Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof
10/01/2009WO2009120903A2 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
10/01/2009WO2009120899A2 G coupled protein receptors associated with myelogenous haematological proliferative disorders and uses thereof
10/01/2009WO2009120811A1 Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
10/01/2009WO2009120810A2 Neurodegenerative disorders
10/01/2009WO2009120801A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
10/01/2009WO2009120684A1 Antibody formulation
10/01/2009WO2009120659A2 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents
10/01/2009WO2009120657A2 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents
10/01/2009WO2009120530A1 Glucagon receptor antagonists
10/01/2009WO2009120380A2 Recombinant rhinovirus vectors
10/01/2009WO2009120339A2 Vectors for delivering disease neutralizing agents
10/01/2009WO2009120306A1 Multivalent vaccine vector for the treatment and inhibition of viral infection
10/01/2009WO2009120273A1 Avian vaccines possessing a positive marker gene
10/01/2009WO2009120178A1 Anti-vegf antibody
10/01/2009WO2009119794A1 Prophylactic/therapeutic agent for infectious disease
10/01/2009WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
10/01/2009WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor
10/01/2009WO2009118642A2 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies
10/01/2009WO2009118523A1 Adjuvant
10/01/2009WO2009118330A1 Vaccine for protection against haemophilus parasuis serotype 4 in piglets
10/01/2009WO2009118273A1 Compositions, methods and kits
10/01/2009WO2009118204A2 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung
10/01/2009WO2009118142A1 Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin' s lymphomas
10/01/2009WO2009117804A1 An anti-cancer cytotoxic monoclonal antibody
10/01/2009WO2009117773A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009WO2009099716A9 Novel vaccines against multiple subtypes of dengue virus
10/01/2009WO2009097291A3 Canine influenza vaccines
10/01/2009WO2009095489A3 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
10/01/2009WO2009092383A3 Products and methods to prevent infection
10/01/2009WO2009090330A3 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections
10/01/2009WO2009079259A9 Antibodies against influenza virus and methods of use thereof
10/01/2009WO2009076542A3 Vaccine directed against adenovirus serotype 14
10/01/2009WO2009022236A8 Immunogen platform
10/01/2009WO2009022236A3 Immunogen platform
10/01/2009WO2008103471A9 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/01/2009WO2008093280A8 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
10/01/2009WO2008017636A8 Genes and proteins of brachyspira hyodysenteriae and uses thereof
10/01/2009WO2008008541A8 Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes
10/01/2009WO2005067620A9 ANTIBODIES TO MAdCAM
10/01/2009US20090249519 Immunization of fish with plant-expressed recombinant proteins
10/01/2009US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/01/2009US20090246852 Therapeutic use of anti-cs1 antibodies
10/01/2009US20090246830 Recombinant influenza viruses for vaccines and gene therapy
10/01/2009US20090246829 Sequence analysis of the tetravalent rotavirus vaccine
10/01/2009US20090246827 Recombinant toxin fragments
1 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 ... 1823